Document Type

Conference Paper/Presentation

Publication Date

6-2019

Advisor(s)

Kirsten Viola, Northwestern University

William Klein, Ph.D., Northwestern University

Abstract

Aβ Oligomers (called AβOs) are small peptides that show early build-up in immunohistochemistry and immunochemistry studies, and appear before plaques in Alzheimer’s development. High levels of AβOs cause loss of memory performance and other pathological changes.Early presentation of AβOs makes them ideal for diagnostic targeting with AβO-specific antibodies Bound to magnetic nanostructures (MNSs) for MRI visibility. Further testing can determine effectiveness of future pharmaceuticals for AD therapy.

Comments

Presented at the 2019 Korea Science Academy Science Fair (KSASF)

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.